Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
The current Johnson & Johnson(JNJ) stock price is $256.50, with a market capitalization of 624.71B. The stock trades at a price-to-earnings (P/E) ratio of 30.78 and offers a dividend yield of 1.97%.
On 2026-08-01, Johnson & Johnson(JNJ) stock moved within a range of $253.29 to $258.47. With shares now at $256.50, the stock is trading +1.3% above its intraday low and -0.8% below the session's peak.
Trading volume for Johnson & Johnson(JNJ) stock has reached 6.78M, versus its average volume of 8.07M.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $274.90 and a low of $164.79.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $274.90 and a low of $164.79.
JNJ News
...
Johnson & Johnson (NYSE:JNJ) has completed its acquisition of Firefly Bio, adding a degrader antibody therapy platform to its oncology toolkit. The company has...
Choosing between Abbott Laboratories (ABT +0.42%) and Johnson & Johnson (JNJ +0.65%) involves weighing steady growth against massive scale. Both healthcare gian...
Analyst ratings
73%
of 26 ratingsMore JNJ News
Cash, cash equivalents and marketable securities were $236.6 million as of June 30, 2026. Contineum (CTNM) believes its cash resources are sufficient to fund it...
Johnson & Johnson announced that the FDA has granted Priority Review to the supplemental Biologics License Application for Rybrevant Faspro, or subcutaneous ami...
Johnson & Johnson will also make an equity investment in Sail. Kyle Grillot / Bloomberg News Johnson & Johnson JNJ -0.45 %decrease; down pointing triangle said...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Johnson & Johnson “announced strategic agreements and collaboration with Sail Biomedicines (Sail), a biotechnology company developing in vivo CAR-T therapies fo...
Key Points Revolution Medicines has a promising cancer drug in development. Even with this medicine's prospects, the stock's valuation looks too frothy. 10 s...
Argus analyst David Toung raised the firm’s price target on Johnson & Johnson to $300 from $290 and keeps a Buy rating on the shares. The firm is citing the com...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.